-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

58th Annual Meeting and Exposition (December 3-6, 2016)

Thursday, December 1, 2016

3:00 PM-7:00 PM


Registration  
Events

Friday, December 2, 2016

7:00 AM-6:00 PM


Registration  
Events

12:00 PM-5:00 PM

Trainee Day


Trainee Day  
Trainee Activities and Services

Training Program Directors Workshop


Training Program Directors' Workshop  
Special-Interest Sessions

12:15 PM-1:15 PM

Trainee Day

1:00 PM-3:00 PM

Training Program Directors Workshop


Didactic Session  
Special-Interest Sessions

1:00 PM-5:00 PM

1:00 PM-5:30 PM

1:00 PM-6:00 PM

1:00 PM-7:00 PM

1:30 PM-2:30 PM

Trainee Day

Trainee Day

Trainee Day

2:00 PM-5:00 PM

2:45 PM-3:45 PM

Trainee Day

Trainee Day

Trainee Day

Trainee Day

3:00 PM-4:00 PM

Training Program Directors Workshop


Breakout 1: Patricia Kritek, MD, EdM  
Special-Interest Sessions

Training Program Directors Workshop


Breakout 1: Timothy Gilligan, MD  
Special-Interest Sessions

4:00 PM-5:00 PM

Training Program Directors Workshop


Breakout 2: Patricia Kritek, MD, EdM  
Special-Interest Sessions

Training Program Directors Workshop


Breakout 2: Timothy Gilligan, MD  
Special-Interest Sessions

Trainee Day

5:00 PM-7:00 PM


Trainee Welcome Reception  
Trainee Activities and Services

Saturday, December 3, 2016

7:00 AM-6:00 PM


Registration  
Events

7:30 AM-9:00 AM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Blood Coagulation and Fibrinolytic Factors

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Myelodysplastic Syndromes—Clinical Studies

CLL: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Results


Chronic Lymphocytic Leukemia  
Education Program


Genomics in Transfusion Medicine  
Scientific Program


Mantle Cell Lymphoma  
Education Program


Myeloma  
Education Program


Myeloproliferative Neoplasms  
Education Program

9:00 AM-9:30 AM

9:00 AM-7:30 PM


Poster Viewing  
Events

9:30 AM-11:00 AM

Regulation of Iron Metabolism

Blood Coagulation and Fibrinolytic Factors

Antithrombotic Therapy

Basic Science and Clinical Practice in Blood Transfusion

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Myelodysplastic Syndromes—Clinical Studies

Myeloma: Biology and Pathophysiology, excluding Therapy


Bone Marrow Failures  
Education Program


Myeloma - Immunotherapy  
Education Program


Ribosomes and Ribosomopathies  
Scientific Program

9:30 AM-11:30 AM

11:00 AM-12:15 PM


Grassroots Network Lunch  
Special-Interest Sessions

11:00 AM-12:30 PM

11:00 AM-5:00 PM


Exhibits Open  
Events

11:15 AM-12:15 PM


ALL in Adolescents and Young Adults  
How I Treat: Bringing Science to Clinical Dilemmas


Biological Insights into Follicular Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Bleeding Disorders  
How I Treat: Bringing Science to Clinical Dilemmas

Career Development Lunch Session


Career Development Lunch- Room 1  
Trainee Activities and Services

Career Development Lunch Session


Career Development Lunch- Room 2  
Trainee Activities and Services

Career Development Lunch Session


Career Development Lunch Sessions  
Trainee Activities and Services


Chronic Myeloid Leukemia  
How I Treat: Bringing Science to Clinical Dilemmas


Disorders of Complement  
How I Treat: Bringing Science to Clinical Dilemmas


Follicular Lymphoma, Evolving Therapy, and Novel Treatment Options  
How I Treat: Bringing Science to Clinical Dilemmas


Hemolytic Anemias  
How I Treat: Bringing Science to Clinical Dilemmas


Myelodysplastic Syndromes  
How I Treat: Bringing Science to Clinical Dilemmas


Novel Agents for Myeloma Therapy  
Meet the Scientist


Obesity, Inflammation, and Thrombosis  
How I Treat: Bringing Science to Clinical Dilemmas

11:30 AM-12:30 PM

12:00 PM-1:30 PM

Hemoglobinopathies, Excluding Thalassemia—Clinical

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Disorders of Platelet Number or Function

Antithrombotic Therapy

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

12:30 PM-1:30 PM


Ham-Wasserman Lecture  
General Sessions

1:30 PM-2:00 PM

2:00 PM-3:30 PM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Disorders of Platelet Number or Function

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy


Anemia in the Young and Old  
Education Program


Cell of Origin and Leukemic Transformation  
Special Scientific Symposia


Chronic Lymphocytic Leukemia  
Education Program


Follicular Lymphomas  
Education Program


Myelodysplastic Syndromes  
Education Program


Special Symposium on Quality  
Special-Interest Sessions

3:30 PM-4:00 PM

4:00 PM-5:30 PM

Regulation of Iron Metabolism

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Myelodysplastic Syndromes—Clinical Studies

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Outcomes Research—Non-Malignant Conditions


Common Consults in Thrombosis  
Education Program

5:30 PM-7:30 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster I  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster I  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster I  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster I  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster I  
Oral and Poster Abstracts

Cell Collection and Processing


711. Cell Collection and Processing: Poster I  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster I  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions


Poster Session I - Presentations  
Oral and Poster Abstracts

6:30 PM-9:00 PM

Sunday, December 4, 2016

7:00 AM-9:00 AM


Hematology Course Directors' Workshop  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

7:30 AM-8:30 AM


ASH Foundation Run/Walk  
Special-Interest Sessions

7:30 AM-9:00 AM

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Pathophysiology of Thrombosis

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Health Services Research—Non-Malignant Conditions


Chronic Myeloid Leukemia  
Education Program


Myeloma - Immunotherapy  
Education Program


Ribosomes and Ribosomopathies  
Scientific Program

7:30 AM-9:15 AM

Regulation of Iron Metabolism

9:00 AM-9:30 AM

9:00 AM-8:00 PM


Poster Viewing  
Events

9:30 AM-11:00 AM

Thalassemia and Globin Gene Regulation

Disorders of Coagulation or Fibrinolysis

Bone Marrow Failure

Acute Myeloid Leukemia: Clinical Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Biology and Pathophysiology, excluding Therapy


Anemia in the Young and Old  
Education Program


Follicular Lymphomas  
Education Program


Genomics in Transfusion Medicine  
Scientific Program


Myeloma  
Education Program


When Antibody Response Goes Awry  
Education Program

9:30 AM-11:30 AM

10:00 AM-5:00 PM


Exhibits Open  
Events

11:00 AM-12:30 PM

11:15 AM-12:15 PM


Acute Promyelocytic Leukemia  
How I Treat: Bringing Science to Clinical Dilemmas


Anemia in the Elderly Patient  
How I Treat: Bringing Science to Clinical Dilemmas


Bone Marrow Failures  
How I Treat: Bringing Science to Clinical Dilemmas


Genetics of Follicular Lymphoma  
Meet the Scientist


Heparin-Induced Thrombocytopenia  
How I Treat: Bringing Science to Clinical Dilemmas


Mantle Cell Lymphoma  
How I Treat: Bringing Science to Clinical Dilemmas


Meet the Blood Editors  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions


Multiple Myeloma  
How I Treat: Bringing Science to Clinical Dilemmas


Reversing Anticoagulation  
How I Treat: Bringing Science to Clinical Dilemmas

Trainee Didactic Session

Trainee Didactic Session

11:15 AM-12:30 PM


ASH Practice Partnership Lunch  
Special-Interest Sessions

11:30 AM-12:30 PM

12:00 PM-1:30 PM

Disorders of Platelet Number or Function

Hematopoietic Stem and Progenitor Biology

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Outcomes Research—Malignant Conditions

12:30 PM-1:30 PM


ASH-EHA Joint Symposium  
General Sessions

1:30 PM-2:00 PM

2:00 PM-4:00 PM

Plenary


Plenary Scientific Session  
General Sessions

4:00 PM-4:30 PM

4:30 PM-6:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis

Hematopoietic Stem and Progenitor Biology

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Myeloproliferative Syndromes: Clinical

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy I  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Chemical Biology and Experimental Therapeutics

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions

6:00 PM-8:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Regulation of Iron Metabolism


102. Regulation of Iron Metabolism: Poster II  
Oral and Poster Abstracts

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis


331. Pathophysiology of Thrombosis: Poster II  
Oral and Poster Abstracts

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster II  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster II  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster II  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster II  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions


Poster Session II - Presentations  
Oral and Poster Abstracts

Monday, December 5, 2016

7:00 AM-8:30 AM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Coagulation or Fibrinolysis

Hematopoietic Stem and Progenitor Biology

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

CLL: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

Adoptive Immunotherapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Health Services Research—Malignant Conditions

Outcomes Research—Malignant Conditions


Myelodysplastic Syndromes  
Education Program


Myeloproliferative Neoplasms  
Education Program


When Antibody Response Goes Awry  
Education Program

7:00 AM-8:45 AM

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

7:00 AM-11:30 AM


Consultative Hematology Course  
Special-Interest Sessions

7:00 AM-5:00 PM


Registration  
Events

9:00 AM-10:00 AM

10:00 AM-10:30 AM

10:00 AM-2:00 PM


Exhibits Open  
Events

10:00 AM-8:00 PM


Poster Viewing  
Events

10:30 AM-12:00 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Granulocytes, Monocytes, and Macrophages

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Pathophysiology of Thrombosis

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma Biology—Non-Genetic Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Basic Science

Myeloma: Biology and Pathophysiology, excluding Therapy

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy II  
Oral and Poster Abstracts

Cell Collection and Processing

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Chemical Biology and Experimental Therapeutics

Health Services Research—Malignant Conditions


Chronic Myeloid Leukemia  
Education Program


Common Consults in Thrombosis  
Education Program


Mantle Cell Lymphoma  
Education Program

12:00 PM-1:30 PM

12:15 PM-1:15 PM


Global Hematology Symposium  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions


Meet the Blood Editors  
Special-Interest Sessions

Trainee Didactic Session

Trainee Didactic Session

1:30 PM-2:30 PM

2:30 PM-2:45 PM

2:45 PM-4:15 PM

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Disorders of Platelet Number or Function

Disorders of Coagulation or Fibrinolysis

Antithrombotic Therapy

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Chronic Myeloid Leukemia: Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Basic and Translational Studies

CLL: Biology and Pathophysiology, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Non-Malignant Conditions


Bone Marrow Failures  
Education Program

4:30 PM-6:00 PM

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Basic Science and Clinical Practice in Blood Transfusion

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Bone Marrow Failure

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Oncogenes and Tumor Suppressors

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Myelodysplastic Syndromes—Basic and Translational Studies

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer

Health Services Research—Non-Malignant Conditions

Health Services Research—Malignant Conditions

Outcomes Research—Malignant Conditions

4:30 PM-6:30 PM

6:00 PM-8:00 PM

Regulation of Iron Metabolism

Thalassemia and Globin Gene Regulation

Hemoglobinopathies, Excluding Thalassemia—Basic and Translational Science

Hemoglobinopathies, Excluding Thalassemia—Clinical

Granulocytes, Monocytes, and Macrophages

Lymphocytes, Lymphocyte Activation, and Immunodeficiency, including HIV and Other Infections

Vascular Wall Biology, Endothelial Progenitor Cells, and Platelet Adhesion, Activation, and Biochemistry

Disorders of Platelet Number or Function

Blood Coagulation and Fibrinolytic Factors

Disorders of Coagulation or Fibrinolysis

Pathophysiology of Thrombosis

Antithrombotic Therapy


332. Antithrombotic Therapy: Poster III  
Oral and Poster Abstracts

Basic Science and Clinical Practice in Blood Transfusion

Hematopoietic Stem and Progenitor Biology

Hematopoiesis: Regulation of Gene Transcription, Cytokines, Signal Transduction, Apoptosis, and Cell Cycle Regulation

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion, and Stromal Stem Cells

Bone Marrow Failure


508. Bone Marrow Failure: Poster III  
Oral and Poster Abstracts

Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation

Molecular Pharmacology and Drug Resistance in Myeloid Diseases

Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases

Acute Lymphoblastic Leukemia: Clinical Studies

Acute Myeloid Leukemia: Clinical Studies

Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation

Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation

Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation

Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Lymphoma—Genetic/Epigenetic Biology

Lymphoma Biology—Non-Genetic Studies

Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies

Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials

Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies

Chronic Myeloid Leukemia: Biology and Pathophysiology, excluding Therapy

Myeloproliferative Syndromes: Clinical

Myeloproliferative Syndromes: Basic Science

Myelodysplastic Syndromes—Basic and Translational Studies

Myelodysplastic Syndromes—Clinical Studies

CLL: Biology and Pathophysiology, excluding Therapy

CLL: Therapy, excluding Transplantation

Myeloma: Biology and Pathophysiology, excluding Therapy

Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy

Myeloma: Therapy, excluding Transplantation

Experimental Transplantation: Basic Biology, Pre-Clinical Models

Adoptive Immunotherapy


703. Adoptive Immunotherapy: Poster III  
Oral and Poster Abstracts

Clinical Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence

Clinical Autologous Transplantation: Results

Clinical Allogeneic Transplantation: Results

Gene Therapy and Transfer


801. Gene Therapy and Transfer: Poster III  
Oral and Poster Abstracts

Chemical Biology and Experimental Therapeutics

Health Services Research—Non-Malignant Conditions

Outcomes Research—Non-Malignant Conditions

Outcomes Research—Malignant Conditions


Poster Session III - Presentations  
Oral and Poster Abstracts

6:15 PM-7:45 PM

Red Cells and Erythropoiesis, Structure and Function, Metabolism, and Survival, Excluding Iron

Oncogenes and Tumor Suppressors

Acute Myeloid Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis

Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies

Chronic Myeloid Leukemia: Therapy

Cell Collection and Processing

Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities

Health Services Research—Malignant Conditions

7:30 PM-9:00 PM


ASH Networking Reception for Female Faculty  
Special-Interest Sessions

Tuesday, December 6, 2016

7:00 AM-1:30 PM


Registration  
Events

7:30 AM-9:00 AM

Late-Breaking Abstracts


Late-Breaking Abstracts Session  
General Sessions

9:30 AM-9:45 AM

9:45 AM-11:15 AM


Presidential Symposium  
General Sessions

11:15 AM-11:30 AM


Business Meeting  
General Sessions

11:30 AM-1:00 PM


Best of ASH  
General Sessions